No true. "Turning to our outlook. Our full year guidance reflects changes in the timing of expected Dispenser sell-in. Our top line sales are expected to be in the range of $90 million to $93 million, resulting in adjusted EBITDA in the range of $9.1 million to $9.3 million or an increase of approximately 68% to 71% over the prior year." Seeking Alpha.